Theoretical Medicine and Bioethics

, Volume 30, Issue 6, pp 427–442 | Cite as

“You are our only hope”: Trading metaphorical “magic bullets” for stem cell “superheroes”

Article

Abstract

In the wake of two recent developments in stem cell research, it is a fitting time to reassess the claim that stem cells will radically transform the concept and function of medicine. The first is the U.S. Food and Drug Administration’s decision in January 2009 to approve Geron Corporation’s Phase I clinical trial using human embryonic stem cells for patients with spinal cord injuries. The second is the National Institutes of Health’s decision to permit federal funding of research using donated IVF human embryos in their July 2009 Guidelines on Human Stem Cell Research. We are now poised to see whether stem cell research can deliver on what it promises. However, what exactly does it promise and how? Moreover, who is doing the promising? Turning to the use of metaphor can help us to answer these questions and enable us to develop a better appreciation of the unique features of promised stem cell therapies. Indeed, metaphors have exerted profound influence in medicine, and it is fitting that we seek new metaphors for new therapies where appropriate. In this case, other metaphors such as magic bullets or the Holy Grail cannot capture what is unique about stem cells. Accordingly, I propose a new metaphor: the stem cell superhero. Stem cell superheroes are characterized by the following traits: they are seemingly capable of fighting the evil of virtually all disease (unlike “magic bullets”) and they seem to be our only hope of doing so, although to summon them we must make difficult moral choices. In the course of assessing the merits of three recent yet covert references to the superhero metaphor, I conclude that this powerful new paradigm employs a problematic logic (i.e., we cannot know that something is “our only hope”), but that the aspiration as such is a good one.

Keywords

Human embryonic stem cells Superhero Medicine Magic bullet Metaphors Cybridization 

References

  1. 1.
    Geron. 2009. News release: Geron receives FDA clearance to begin world’s first human clinical trial of embryonic stem cell based therapy. http://www.geron.com/grnopc1clearance/grnopc1-pr.html. Accessed 5 Nov 2009.
  2. 2.
    National Institutes of Health. 2009. NIH guidelines on human stem cell research. http://stemcells.nih.gov/policy/2009guidelines.htm. Accessed 5 Nov 2009.
  3. 3.
    Nussbaum, M.C. 1997. Poetic justice: The literary imagination and public life. Boston: Beacon Press.Google Scholar
  4. 4.
    Sontag, S. 2001. Illness as metaphor and AIDS and its metaphors. New York, NY: Picador USA.Google Scholar
  5. 5.
    Callahan, D. 2006. What price better health?: Hazards of the research imperative. Los Angeles, CA: University of California Press.Google Scholar
  6. 6.
    Storch, J. 1999. Moral relationships between nurse and client: The influence of metaphors. In Readings in biomedical ethics: A Canadian focus, 2nd ed, ed. E.-H.W. Kluge, 143–153. Scarborough, ON: Prentice Hall.Google Scholar
  7. 7.
    Childress, J.F. 1997. Practical reasoning in bioethics. Bloomington, IN: Indiana University Press.Google Scholar
  8. 8.
    Gibbs, R. 2000. Why ethics?: Signs of responsibilities. Princeton, NJ: Princeton University Press.Google Scholar
  9. 9.
    Prüll, C.R. 2003. Part of a scientific master plan? Paul Ehrlich and the origins of his receptor concept. Medical History 47: 332–356.Google Scholar
  10. 10.
    Beers, M.H., and R. Berkow. 1999. The Merck manual of diagnosis and therapy. Whitehouse Station, NJ: Merck Research Laboratories.Google Scholar
  11. 11.
    Duffin, J. 1999. History of medicine: A scandalously short introduction. Toronto, ON: University of Toronto Press.Google Scholar
  12. 12.
    Geron. 2009. News release: Geron comments on FDA hold on spinal cord injury trial. http://www.geron.com/media/pressview.aspx?id=1188. Accessed 5 Nov 2009.
  13. 13.
    Siminovitch, L., E.A. McCulloch, and J.E. Till. 1963. The distribution of colony-forming cells among spleen colonies. American Journal of Cell Physiology 62: 327–336.CrossRefGoogle Scholar
  14. 14.
    Thomson, J.A., J. Itskovitz-Eldor, S.S. Shapiro, M.A. Waknitz, J.J. Swiergiel, V.S. Marshall, and J.M. Jones. 1998. Embryonic stem cell lines derived from human blastocysts. Science 282: 1145–1147.CrossRefGoogle Scholar
  15. 15.
    Shamblott, M.J., J. Axelman, S. Wang, E.M. Bugg, J.W. Littlefield, P.J. Donovan, P.D. Lumenthal, G.R. Huggins, and J. Gearhart. 1998. Derivation of pluripotent stem cells from cultured human primordial germ cells. Proceedings of the National Academy of Sciences 95(23): 13726–13731.Google Scholar
  16. 16.
    Macchiarini, P., P. Jungebluth, T. Go, M. Asnaghi, L. Rees, T. Cogan, A. Dodson, J. Martorell, S. Bellini, and P. Parnigotto. 2008. Clinical transplantation of a tissue-engineered airway. Lancet 372(9655): 2023–2030.CrossRefGoogle Scholar
  17. 17.
    Giacomini, M., F. Baylis, and J.S. Robert. 2007. Banking on it: Public policy and the ethics of stem cell research and development. Social Science and Medicine 65: 1490–1500.CrossRefGoogle Scholar
  18. 18.
    Yu, J., M.A. Vodyanik, K. Smuga-Otto, J. Antosiewicz-Bourget, J.L. Frane, S. Tian, J. Nie, G.A. Jonsdottir, V. Ruotti, R. Stewart, I.I. Slukvin, J.A. Thomson, and A. James. 2008. Induced pluripotent stem cell lines derived from human somatic cells. Obstetrical and Gynecological Survey 63: 154–155.CrossRefGoogle Scholar
  19. 19.
    Takahashi, K., K. Tanabe, M. Ohnuki, M. Narita, T. Ichisaka, K. Tomoda, and S. Yamanaka. 2007. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131: 861–872.CrossRefGoogle Scholar
  20. 20.
    Cyranoski, D. 2008. Stem cells: 5 things to know before jumping on the iPS bandwagon. Nature 452: 406–408.CrossRefGoogle Scholar
  21. 21.
    Cheshire, W.P. 2004. In search of the philosopher’s clone: Immortality through replication. In Aging, death and the quest for immortality, ed. C.D. Mitchell, R.D. Orr, and S.A. Salladay, 175–192. Grand Rapids, MI: Eerdmans.Google Scholar
  22. 22.
    Ackerknecht, E.H. 1982. A Short history of medicine. Baltimore: Johns Hopkins University Press.Google Scholar
  23. 23.
    Sigerist, H.E. 1967. The medicine man. In A history of medicine, vol. 1, 161–189. Oxford: Oxford University Press.Google Scholar
  24. 24.
    Stanford Report. 2004. 5 Questions: Irving Weissman on embryonic stem cell research. http://news-service.stanford.edu/news/2004/august4/med-5questions-84.html. Accessed 5 Nov 2009.
  25. 25.
    Conger, K. 2009. News release: NIH stem cell rules seriously flawed, says Stanford expert. http://med.stanford.edu/news_releases/2009/july/nih-reax.html. Accessed 5 Nov 2009.
  26. 26.
    Vergano, D. 2003. States dive into stem cell debates. USA Today. http://www.usatoday.com/news/health/2004-04-20-stem-cell-cover_x.htm. Accessed 21 Dec 2009.
  27. 27.
    Leschner, A.I. and J.A. Thomson. 2007. Standing in the way of stem cell research. The Washington Post. http://www.washingtonpost.com/wp-dyn/content/article/2007/12/02/AR2007120201636.html. Accessed 21 Dec 2009.
  28. 28.
    Blakemore, C. 2008. Embryo research is controversial … But would you refuse the treatment? The Times Online. http://www.timesonline.co.uk/tol/comment/columnists/guest_contributors/article3655941.ece. Accessed 27 Nov 2009.
  29. 29.
    Shorter, E. 1997. The history of the doctor-patient relationship. In Companion encyclopaedia of the history of medicine, vol. 2, ed. W.F. Bynum and R. Porter, 783–800. New York, NY: Routledge.Google Scholar
  30. 30.
    Hwang, W.S., Y.J. Ryu, J.H. Park, E.S. Park, E.G. Lee, J.M. Koo, H.Y. Jeon, B.C. Lee, S.K. Kang, S.J. Kim, C. Ahn, J.H. Hwang, K.Y. Park, J.B. Cibelli, and S.Y. Moon. 2004. Evidence of a pluripotent human embryonic stem cell line derived from a cloned blastocyst. Science 303: 1669–1674.CrossRefGoogle Scholar
  31. 31.
    Hwang, W.S., S.I. Roh, B.C. Lee, S.K. Kang, D.K. Kwon, S. Kim, S.J. Kim, S.W. Park, H.S. Kwon, C.K. Lee, J.B. Lee, J.M. Kim, C. Ahn, S.H. Paek, S.S. Chang, J.J. Koo, H.S. Yoon, J.H. Hwang, Y.Y. Hwang, Y.S. Park, S.K. Oh, H.S. Kim, J.H. Park, S.Y. Moon, and G. Schatten. 2005. Patient-specific embryonic stem cells derived from human SCNT blastocysts. Science 308: 1777–1783.CrossRefGoogle Scholar
  32. 32.
    Mandavilli, A. 2005. Profile: Woo-Suk Hwang. Nature Medicine 11: 464.CrossRefGoogle Scholar
  33. 33.
    Song, S.Y. 2007. The Hwang Woo-Suk scandal hasn’t ended. Journal of the Korean Bioethics Association 8: 1–10.CrossRefGoogle Scholar
  34. 34.
    Okie, S. 2005. An offshore haven for human embryonic stem cell research? New England Journal of Medicine 353: 1645–1649.CrossRefGoogle Scholar
  35. 35.
    Kennedy, D. 2006. Retraction of Hwang et al., Science 308(5729): 1777–1783. Retraction of Hwang et al., Science 303(5664): 1669–1674. Science 311: 335.CrossRefGoogle Scholar
  36. 36.
    Park J.-M. 2009. Disgraced cloning scientist Hwang Woo-Suk found guilty of embezzlement. Chicago Tribune. http://www.chicagotribune.com/news/nationworld/la-fg-korea-clone-scientist27-2009oct27,0,1990328.story. Accessed 5 Nov 2009.
  37. 37.
    Häyry, M., and T. Takala. 2007. Benefiting from past wrongdoing, human embryonic stem cell lines, and the fragility of the German legal position. Bioethics 21: 150–159.CrossRefGoogle Scholar
  38. 38.
    Ullrich, D. 2003. Concurring visions: Human dignity in the Canadian charter of rights and freedoms and the basic law of the Federal Republic of Germany. Global Jurist Frontiers 3(1): Article 1. http://www.bepress.com/gj/frontiers/vol3/iss1/art1/. Accessed 27 May 2009.
  39. 39.
    German National Ethics Council. 2001. On the import of human embryonic stem cells. Berlin. http://www.ethikrat.org/_english/publications/stem_cells/Opinion_Import-HESC.pdf. Accessed 5 Nov 2009.
  40. 40.
    Deutschen Forschungsgemeinschaft–DFG. 2001. Empfehlungen der Deutschen Forschungsgemeinschaft zur Forschung mit menschlichen Stammzellen. Bonn. Excerpts translated by Chris Kaposy. http://www.dfg.de/aktuelles_presse/reden_stellungnahmen/download/empfehlungen_stammzellen_hintergrund_03_05_01.pdf. Accessed 5 Nov 2009.
  41. 41.
    Human Fertilization and Embryology Authority (HFEA). 2008. 17 January. HFEA statement on licensing of applications to carry out research using human-animal cytoplasmic hybrid embryos. http://www.hfea.gov.uk/418.html. Accessed 5 Nov 2009.
  42. 42.
    Human Fertilization and Embryology Authority (HFEA). 2007. 5 September. HFEA statement on its decision regarding human embryos. http://www.hfea.gov.uk/455.html. Accessed 5 November 2009.
  43. 43.
    Genetic Interest Group. 2008. Cytoplasmic hybrid embryos. Last updated 11 Sept 2008. http://www.gig.org.uk/cytoplasmichybridembryos.htm. Accessed 5 Nov 2009.
  44. 44.
    Baylis, F. 2008. Animal eggs for stem cell research: A path not worth taking. American Journal of Bioethics 8(12): 18–32.CrossRefGoogle Scholar
  45. 45.
    Jones, D.A. 2009. What does the British public think about human-animal hybrid embryos? Journal of Medical Ethics 24: 168–170.CrossRefGoogle Scholar
  46. 46.
    Brown, G. 2008. Why I believe stem cell researchers deserve our backing. The Observer. 18 May: 31.Google Scholar
  47. 47.
    St.John, J., and R. Lovell-Badge. 2007. Human–animal cytoplasmic hybrid embryos, mitochondria, and an energetic debate. Nature Cell Biology 9: 988–992.CrossRefGoogle Scholar
  48. 48.
    Nightingale, P., and P. Martin. 2004. The myth of the biotech revolution. Trends in Biotechnology 22: 564–569.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2009

Authors and Affiliations

  1. 1.King’s University College at the University of Western OntarioLondonCanada

Personalised recommendations